IQ EQ FUND MANAGEMENT IRELAND Ltd Purchases 19,575 Shares of Tempus AI, Inc. (NASDAQ:TEM)

IQ EQ FUND MANAGEMENT IRELAND Ltd raised its position in shares of Tempus AI, Inc. (NASDAQ:TEM) by 429.5% during the fourth quarter, HoldingsChannel.com reports. The fund owned 24,133 shares of the company’s stock after buying an additional 19,575 shares during the quarter. IQ EQ FUND MANAGEMENT IRELAND Ltd’s holdings in Tempus AI were worth $815,000 at the end of the most recent quarter.

A number of other large investors have also recently bought and sold shares of the business. Geode Capital Management LLC increased its holdings in Tempus AI by 0.4% in the third quarter. Geode Capital Management LLC now owns 133,171 shares of the company’s stock worth $7,537,000 after purchasing an additional 539 shares in the last quarter. Prestige Wealth Management Group LLC grew its position in shares of Tempus AI by 910.4% during the 4th quarter. Prestige Wealth Management Group LLC now owns 1,071 shares of the company’s stock worth $36,000 after buying an additional 965 shares during the period. Farther Finance Advisors LLC bought a new stake in shares of Tempus AI in the 4th quarter valued at $34,000. First Horizon Advisors Inc. lifted its position in shares of Tempus AI by 207.9% during the 4th quarter. First Horizon Advisors Inc. now owns 1,641 shares of the company’s stock valued at $55,000 after acquiring an additional 1,108 shares during the period. Finally, FNY Investment Advisers LLC bought a new position in Tempus AI during the fourth quarter worth $67,000. 24.22% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Tempus AI

In related news, major shareholder Bradley A. Keywell sold 265,000 shares of the business’s stock in a transaction dated Friday, January 17th. The shares were sold at an average price of $35.10, for a total value of $9,301,500.00. Following the transaction, the insider now directly owns 15,218,365 shares of the company’s stock, valued at approximately $534,164,611.50. The trade was a 1.71 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Eric P. Lefkofsky sold 3,240,234 shares of the firm’s stock in a transaction dated Thursday, February 27th. The stock was sold at an average price of $58.75, for a total transaction of $190,363,747.50. Following the sale, the chief executive officer now owns 4,895,589 shares of the company’s stock, valued at $287,615,853.75. This trade represents a 39.83 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 5,598,969 shares of company stock worth $317,194,162 in the last 90 days.

Analysts Set New Price Targets

Several research firms have weighed in on TEM. JPMorgan Chase & Co. downgraded shares of Tempus AI from an “overweight” rating to a “neutral” rating and lifted their price target for the company from $50.00 to $55.00 in a research note on Tuesday, February 25th. Needham & Company LLC upped their price target on Tempus AI from $56.00 to $70.00 and gave the stock a “buy” rating in a research note on Tuesday, February 25th. William Blair reiterated a “market perform” rating on shares of Tempus AI in a report on Tuesday, February 25th. Wolfe Research downgraded Tempus AI from a “strong-buy” rating to a “hold” rating in a report on Wednesday, February 26th. Finally, Loop Capital reduced their price target on shares of Tempus AI from $57.00 to $52.00 and set a “buy” rating for the company in a research report on Tuesday, January 14th. Six investment analysts have rated the stock with a hold rating and six have given a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $61.18.

Tempus AI Stock Down 2.4 %

Shares of TEM stock opened at $51.97 on Friday. The company has a quick ratio of 2.55, a current ratio of 2.69 and a debt-to-equity ratio of 8.17. Tempus AI, Inc. has a 52-week low of $22.89 and a 52-week high of $91.45. The company has a 50-day simple moving average of $58.13 and a two-hundred day simple moving average of $51.48.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.